GT
ARNA

Glenmede Trust’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Glenmede Trust’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-18
Closed – – 2756
2016
Q1 		$0 Hold
18
– – ﹤0.01% 2754
2015
Q4 		$0 Hold
18
– – ﹤0.01% 2808
2015
Q3 		$0 Buy
+18
New +$611 ﹤0.01% 2869
2013
Q3 		– Sell
-800
Closed -$61K – 2283
2013
Q2 		$61K Buy
+800
New +$65.3K ﹤0.01% 1466

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Glenmede Trust's ARNA Position: Q2 2016 in Review

Glenmede Trust sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2016, closing a stake of 18 shares.

Glenmede Trust first reported a position in ARNA in Q2 2013 and held it in 4 quarters. The position peaked at $61K in Q2 2013. 119 funds tracked by Wall St. Rank hold ARNA as of Q2 2016.

  • Glenmede Trust reported no remaining Arena Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Glenmede Trust sold 18 Arena Pharmaceuticals Inc shares in Q2 2016.
  • Glenmede Trust first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Glenmede Trust's Arena Pharmaceuticals Inc position peaked at $61K in Q2 2013.
  • 119 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2016.

Based on Glenmede Trust's 13F filing for Q2 2016, filed 5 Aug 2016.